What does Zymeworks, Inc. do?

Jun 22 2025 07:23 PM IST
share
Share Via
Zymeworks, Inc. is a clinical-stage biopharmaceutical company focused on developing bio-therapeutics for cancer treatment, with a market cap of approximately $859.90 million. As of March 2025, it reported net sales of $27 million and a net loss of $23 million.
Overview:
Zymeworks, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 27 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -23 Million (Quarterly Results - Mar 2025)
Market-cap: USD 859.90 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -0.81
Return on Equity: -29.66%
Price to Book: 2.65

Contact Details:
Address: 540-1385 West 8Th Avenue, VANCOUVER BC: V6H 3V9
Tel: 1 604 6781388
Website: https://www.zymeworks.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Zymeworks Stock Hits Day Low of $16 Amid Price Pressure
Nov 10 2025 05:58 PM IST
share
Share Via
Zymeworks, Inc. Hits New 52-Week High at $19.98
Oct 31 2025 04:33 PM IST
share
Share Via
Zymeworks, Inc. Hits New 52-Week High of USD 19.50
Oct 15 2025 05:18 PM IST
share
Share Via
Is Zymeworks, Inc. technically bullish or bearish?
Sep 20 2025 08:28 PM IST
share
Share Via
Is Zymeworks, Inc. overvalued or undervalued?
Jun 25 2025 09:38 AM IST
share
Share Via
Is Zymeworks, Inc. technically bullish or bearish?
Jun 25 2025 09:22 AM IST
share
Share Via
How big is Zymeworks, Inc.?
Jun 22 2025 06:32 PM IST
share
Share Via